Novel fidaxomicin antibiotics through site-selective catalysis

Fidaxomicin is a narrow spectrum antibiotic, and broadening its activity through structural modification could provide new antibiotics. Here semi-synthetic derivatives are prepared through site-selective esterification and allylic substitution to efficiently modify or substitute key carbohydrate moi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David Dailler, Andrea Dorst, Daniel Schäfle, Peter Sander, Karl Gademann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/c32e82beff5d448d939c9d14cc5a1314
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c32e82beff5d448d939c9d14cc5a1314
record_format dspace
spelling oai:doaj.org-article:c32e82beff5d448d939c9d14cc5a13142021-12-02T17:01:35ZNovel fidaxomicin antibiotics through site-selective catalysis10.1038/s42004-021-00501-62399-3669https://doaj.org/article/c32e82beff5d448d939c9d14cc5a13142021-05-01T00:00:00Zhttps://doi.org/10.1038/s42004-021-00501-6https://doaj.org/toc/2399-3669Fidaxomicin is a narrow spectrum antibiotic, and broadening its activity through structural modification could provide new antibiotics. Here semi-synthetic derivatives are prepared through site-selective esterification and allylic substitution to efficiently modify or substitute key carbohydrate moieties.David DaillerAndrea DorstDaniel SchäflePeter SanderKarl GademannNature PortfolioarticleChemistryQD1-999ENCommunications Chemistry, Vol 4, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Chemistry
QD1-999
spellingShingle Chemistry
QD1-999
David Dailler
Andrea Dorst
Daniel Schäfle
Peter Sander
Karl Gademann
Novel fidaxomicin antibiotics through site-selective catalysis
description Fidaxomicin is a narrow spectrum antibiotic, and broadening its activity through structural modification could provide new antibiotics. Here semi-synthetic derivatives are prepared through site-selective esterification and allylic substitution to efficiently modify or substitute key carbohydrate moieties.
format article
author David Dailler
Andrea Dorst
Daniel Schäfle
Peter Sander
Karl Gademann
author_facet David Dailler
Andrea Dorst
Daniel Schäfle
Peter Sander
Karl Gademann
author_sort David Dailler
title Novel fidaxomicin antibiotics through site-selective catalysis
title_short Novel fidaxomicin antibiotics through site-selective catalysis
title_full Novel fidaxomicin antibiotics through site-selective catalysis
title_fullStr Novel fidaxomicin antibiotics through site-selective catalysis
title_full_unstemmed Novel fidaxomicin antibiotics through site-selective catalysis
title_sort novel fidaxomicin antibiotics through site-selective catalysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/c32e82beff5d448d939c9d14cc5a1314
work_keys_str_mv AT daviddailler novelfidaxomicinantibioticsthroughsiteselectivecatalysis
AT andreadorst novelfidaxomicinantibioticsthroughsiteselectivecatalysis
AT danielschafle novelfidaxomicinantibioticsthroughsiteselectivecatalysis
AT petersander novelfidaxomicinantibioticsthroughsiteselectivecatalysis
AT karlgademann novelfidaxomicinantibioticsthroughsiteselectivecatalysis
_version_ 1718382109321592832